Search

Background Gastrointestinal stromal tumors (GISTs) extremely and rarely metastasize to the skin, and such metastases have not been well characterized. Methods Retrospective analysis of clinicopathological data of patients with skin metastasis of a GIST (SM-GIST) admitted to Xiangya Hospital (Changsha, Hunan, China) and literature review were conducted. Results Including our 4 cases, a total of 17 cases have been reported to date. The mean age of the patients was 55.4 years (29~70 years) and there was not sex predominance (male 10 and female 7). Primary tumors were often located in the stomach (n=9), duodenum (n=2) and small bowel (n=2). Meanwhile, SM-GIST mainly occurred in head and face (n=6), extremities (n=6), followed by abdomen wall (n=5), back (n=3) and chest (n=2). Mutation analysis revealed that the frequency of wild-type GIST (WT-GIST), exon 9, 11 and 13 mutations was 6, 1, 4 and 1, respectively. The average time to SM-GIST was 4.22 years, specifically 4.59 years in gastric and 3.8 years in non-gastric. Moreover, for the resection only group (including chemotherapy), such average time was 3.63 years, while for the combined group (resection and tyrosine kinase inhibitors (TKIs)), it was about 4.74 years. The mean survival was approximately 6.2 years. However, after the diagnosis of SM-GIST, survival was only about 1.69 years. Conclusion SM-GIST is a rare malignant condition. Non-gastric GIST, surgery without TKIs, high invasiveness and tumor burden, and molecular subtype (mutation in exon 9, 11 and wild-type) may be conducive to the development of SM-GIST. Additionally, it is also a sign of poor prognosis.

Purpose The surgical or endoscopic resection is the current treatment modality for 2-5 cm gastric gastrointestinal stromal tumors (GISTs). However, evidence is lacking as to which treatment modality is better. Our objective is to provide a new reference for the standardization of the treatment of 2-5 cm gastric GISTs. Patients and Methods A retrospective study was conducted on 177 patients who underwent resection for 2-5cm gastric GISTs between January 2007 and July 2019 at Xiangya Hospital of Central South University. The cases were divided into surgical group (n=118) and endoscopic group (n=59). The clinical data, pathological and genetic characteristics, short- and long-term outcomes were compared. Results Symptoms showed more obvious in the surgical group including abdominal pain and bleeding. In the endoscopic group, tumor size was smaller (p

Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal tumor in the digestive tract. Tyrosine kinase inhibitors (TKIs), represented by imatinib, sunitinib, and regorafenib, have become the main treatment for recurrent and metastatic GISTs. With the wide application of mutation analysis and the precision medicine, molecular characteristics have been determined that not only predict the prognosis of patients with recurrent and metastatic GISTs, but also are closely related to the efficacy of first-, second- and third-line TKIs for GISTs, as well as other TKIs. Despite the significant effects of TKIs, the emergence of primary and secondary resistance ultimately leads to treatment failure and tumor progression. Currently, due to the signal transmission of KIT/PDGFRA during onset and tumor progression, strategies to counteract drug resistance include the replacement of TKIs and the development of new drugs that are directed towards carcinogenic mutations. In addition, it is also the embodiment of precision medicine for GISTs to explore new carcinogenic mechanisms and develop new drugs relying on new biotechnology. Surgery can benefit specific patients but its major purpose is to diminish the resistant clones. However, the prognosis of recurrent and metastatic patients is still unsatisfactory. Therefore, it is worth paying attention to how to maximize the benefits for patients.

Ni/HZSM-5 catalysts were prepared using the impregnation method. The HZSM-5 and impregnated Ni/HZSM-5 catalysts were characterized by Brunauer–Emmett–Teller and X-ray diffraction. The HZSM-5 and Ni/HZSM-5 catalysts were used for prairie cordgrass (PCG) thermal conversion in a two-stage catalytic pyrolysis system. The products contained gas, bio-oil, and bio-char. The gas and bio-oil were analyzed by gas chromatography and gas chromatography–mass spectrometry separately. Higher heating values and elemental composition of bio-char were determined. The results indicated that 12% Ni/HZSM-5 treatment yielded the highest amount of gasoline fraction for hydrocarbons and showed a robust ability to upgrade bio-oil vapor.

Although most of jet fuels are currently made from petroleum, nonfood oilseeds such as flax and canola seeds may be an alternative for renewable jet fuel production in the near future. Vegetable oils produced from those oilseeds can be upgraded to liquid hydrocarbons to produce renewable jet fuels. The production efficiency and cost are heavily relied on the vegetable oil fatty acid profile (FAP). Previous research indicated that vegetable oil FAP is affected by oilseed species and oil extraction conditions. Cold press oil extractions from flax and canola seeds were conducted. The effect of the frequency controlling the screw rotating speed on the oil extraction efficiency and quality was discussed. Characterization of the vegetable oils produced, including density, pH value, viscosity, moisture, element component, heating value and FAP, was carried out. The residual oil contents left in the cold press meals were also determined. The results show that the oil extraction efficiency of oilseeds incr...